Rhumbline Advisers Has $65.10 Million Stake in Humana Inc. (NYSE:HUM)

Rhumbline Advisers lifted its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 3.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 246,037 shares of the insurance provider's stock after acquiring an additional 7,909 shares during the quarter. Rhumbline Advisers owned 0.20% of Humana worth $65,101,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the business. FPC Investment Advisory Inc. acquired a new position in shares of Humana in the 4th quarter valued at approximately $27,000. Centricity Wealth Management LLC bought a new stake in Humana in the fourth quarter valued at about $30,000. LFA Lugano Financial Advisors SA raised its stake in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after buying an additional 45 shares in the last quarter. OFI Invest Asset Management bought a new position in Humana during the 4th quarter worth approximately $33,000. Finally, Transce3nd LLC bought a new position in Humana during the 4th quarter worth approximately $38,000. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Trading Down 1.7%

NYSE HUM traded down $4.00 on Thursday, hitting $226.83. 1,694,376 shares of the stock were exchanged, compared to its average volume of 1,776,371. The company's 50-day moving average price is $254.92 and its two-hundred day moving average price is $265.74. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 52-week low of $212.45 and a 52-week high of $406.46. The company has a market capitalization of $27.38 billion, a price-to-earnings ratio of 22.80, a P/E/G ratio of 2.05 and a beta of 0.49.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a return on equity of 11.70% and a net margin of 1.02%. The firm had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. During the same period in the previous year, the firm earned $7.23 earnings per share. Humana's quarterly revenue was up 8.4% on a year-over-year basis. Research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.56%. Humana's payout ratio is 25.04%.

Wall Street Analyst Weigh In

HUM has been the topic of several research analyst reports. Raymond James upgraded Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective on the stock in a research note on Thursday, May 1st. Wall Street Zen upgraded shares of Humana from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Robert W. Baird lifted their price target on shares of Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a report on Tuesday, April 15th. Barclays dropped their price objective on shares of Humana from $322.00 to $273.00 and set an "equal weight" rating on the stock in a research note on Monday. Finally, Truist Financial cut their target price on shares of Humana from $325.00 to $305.00 and set a "hold" rating on the stock in a report on Monday, May 12th. Sixteen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $284.48.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.